# Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
Canonical URL: https://biopharmsignal.com/news/CLSD/clearside-biomedical-data-featured-in-six-presentations-at-association-for-research-in-vision-and-ophthalmology-arvo-2025-meeting
Ticker: CLSD
Company: Clearside Biomedical
Source: Clearside Biomedical
Published: 2025-05-09 11:05 EST
Original Source URL: https://ir.clearsidebio.com
## Summary

Strong Clinical Evidence Supports Use of the Suprachoroidal Platform in Expanding the Standard of Care for the Treatment of Multiple Macular Diseases ALPHARETTA, Ga., May 09, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical

## Article Body
Strong Clinical Evidence Supports Use of the Suprachoroidal Platform in Expanding the Standard of Care for the Treatment of Multiple Macular Diseases ALPHARETTA, Ga., May 09, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical
## Recent Company News
- 2025-11-24 12:05 EST — [Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process](https://biopharmsignal.com/news/CLSD/clearside-biomedical-to-pursue-strategic-sale-of-its-business-through-voluntary-chapter-11-process) — Source: Clearside Biomedical
- 2025-08-26 12:05 EST — [Clearside Biomedical Announces Multiple Presentations on Suprachoroidal Delivery to be Featured at the 25th EURETINA Congress](https://biopharmsignal.com/news/CLSD/clearside-biomedical-announces-multiple-presentations-on-suprachoroidal-delivery-to-be-featured-at-the-25th-euretina-congress) — Source: Clearside Biomedical
- 2025-07-23 11:05 EST — [Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada](https://biopharmsignal.com/news/CLSD/clearside-biomedical-announces-approval-of-xiperer-suprachoroidal-treatment-for-uveitic-macular-edema-in-canada) — Source: Clearside Biomedical
- 2025-07-17 11:05 EST — [Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline](https://biopharmsignal.com/news/CLSD/clearside-biomedical-announces-plan-to-explore-strategic-alternatives-to-advance-its-proprietary-suprachoroidal-space-scsr-delivery-platform-and-promising-ophthalmology-pipeline) — Source: Clearside Biomedical
- 2025-06-17 11:05 EST — [Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting](https://biopharmsignal.com/news/CLSD/clearside-biomedical-announces-multiple-presentations-to-be-featured-at-the-clinical-trials-at-the-summit-meeting) — Source: Clearside Biomedical
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)